Meningococcal vaccine evolution

Meningococcal vaccine evolution

Neisseria meningitidis is a leading cause of bacterial sepsis and meningitis worldwide. Although polysaccharide and glycoconjugate vaccines have been developed for serogroups A, C, Y and W-135, currently there are no broadly effective vaccines available for the prevention of meningococcal B disease....

Full description

Bibliographic Details
Main Authors: Gianni Bona, Carla Guidi
Format: Article
Language:English
Published: SEEd 2012-06-01
Series:Clinical Management Issues
Subjects:
Meningococcal disease
Neisseria meningitidis
Meningococcal vaccines
Meningococcal conjugate vaccines
Online Access:https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/627
id doaj-2d9c35d70ea3482e8117adeef3b88266
record_format Article
spelling doaj-2d9c35d70ea3482e8117adeef3b882662020-11-24T21:09:57ZengSEEdClinical Management Issues1973-48322283-31372012-06-0162596610.7175/cmi.v6i2.627591Meningococcal vaccine evolutionGianni Bona0Carla Guidi1Clinica Pediatrica, Dipartimento di Scienze Mediche, Università degli Studi del Piemonte Orientale “A. Avogadro”, NovaraClinica Pediatrica, Dipartimento di Scienze Mediche, Università degli Studi del Piemonte Orientale “A. Avogadro”, NovaraNeisseria meningitidis is a leading cause of bacterial sepsis and meningitis worldwide. Although polysaccharide and glycoconjugate vaccines have been developed for serogroups A, C, Y and W-135, currently there are no broadly effective vaccines available for the prevention of meningococcal B disease. A general overview of the burden of the disease and the strains prevalence in the world with the focus in particular on the Italian situation is provided in this article, together with the vaccinations developed and under evaluation.https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/627Meningococcal diseaseNeisseria meningitidisMeningococcal vaccinesMeningococcal conjugate vaccines
collection DOAJ
language English
format Article
sources DOAJ
author Gianni Bona
Carla Guidi
spellingShingle Gianni Bona
Carla Guidi
Meningococcal vaccine evolution
Clinical Management Issues
Meningococcal disease
Neisseria meningitidis
Meningococcal vaccines
Meningococcal conjugate vaccines
author_facet Gianni Bona
Carla Guidi
author_sort Gianni Bona
title Meningococcal vaccine evolution
title_short Meningococcal vaccine evolution
title_full Meningococcal vaccine evolution
title_fullStr Meningococcal vaccine evolution
title_full_unstemmed Meningococcal vaccine evolution
title_sort meningococcal vaccine evolution
publisher SEEd
series Clinical Management Issues
issn 1973-4832
2283-3137
publishDate 2012-06-01
description Neisseria meningitidis is a leading cause of bacterial sepsis and meningitis worldwide. Although polysaccharide and glycoconjugate vaccines have been developed for serogroups A, C, Y and W-135, currently there are no broadly effective vaccines available for the prevention of meningococcal B disease. A general overview of the burden of the disease and the strains prevalence in the world with the focus in particular on the Italian situation is provided in this article, together with the vaccinations developed and under evaluation.
topic Meningococcal disease
Neisseria meningitidis
Meningococcal vaccines
Meningococcal conjugate vaccines
url https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/627
work_keys_str_mv AT giannibona meningococcalvaccineevolution
AT carlaguidi meningococcalvaccineevolution
_version_ 1716756913128996864

Similar Items